|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


* NIEHS/NIH, Laboratory of Respiratory Biology, Durham, North Carolina, USA; and
Harvard University Department of Environmental Health, Boston, Massachusetts, USA
1 Correspondence: NIH/NIEHS MD 2–01, 111 T.W. Alexander Dr., Durham, NC 27709, USA. E-mail: imani{at}niehs.nih.gov
Double-stranded RNA (dsRNA) is a potent signal to the host immune system for the presence of an ongoing viral infection. The presence of dsRNA, intracellularly or extracellularly, leads to the induction of innate inflammatory cytokines in many cell types including epithelial cells. However, the cell surface receptor for recognition of extracellular dsRNA is not yet determined. Here, we report that extracellular dsRNA is recognized and internalized by scavenger receptor class-A (SR-A). Treatment of human epithelial cells with specific antagonists of SR-A or with an anti-SR-A antibody significantly inhibited dsRNA induction of tumor necrosis factor (TNF)-
, interleukin (IL)-6, IL-8, and regulated on activation normal T-cell expressed and secreted (RANTES). Furthermore, intranasal dsRNA treatment of SR-A-deficient (SR-A–/–) mice showed a significant decrease in the expression of inflammatory cytokines and a corresponding decrease in the accumulation of polymorphonuclear leukocytes (PMNs) in lungs. These data provide direct evidence that SR-A is a novel cell surface receptor for dsRNA, and therefore, SR-A may play a role in antiviral immune responses.—Limmon, G. V., Arredouani, M., McCann, K. L., Corn Minor, R. A., Kobzik, L., Imani, L. Scavenger receptor class-A is a novel cell surface receptor for double-stranded RNA.
Key Words: lung epithelium inflammation virus infection
This article has been cited by other articles:
![]() |
I. Tirapu, B. Giquel, L. Alexopoulou, S. Uematsu, R. Flavell, S. Akira, and S. S. Diebold PolyI:C-induced reduction in uptake of soluble antigen is independent of dendritic cell activation Int. Immunol., July 1, 2009; 21(7): 871 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Cho, R. J. C. Albuquerque, M. E. Kleinman, V. Tarallo, A. Greco, M. Nozaki, M. G. Green, J. Z. Baffi, B. K. Ambati, M. De Falco, et al. Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth PNAS, April 28, 2009; 106(17): 7137 - 7142. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Trifonova, G. F. Doncel, and R. N. Fichorova Polyanionic Microbicides Modify Toll-Like Receptor-Mediated Cervicovaginal Immune Responses Antimicrob. Agents Chemother., April 1, 2009; 53(4): 1490 - 1500. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shibamiya, K. Hersemeyer, T. Schmidt Woll, D. Sedding, J.-M. Daniel, S. Bauer, T. Koyama, K. T. Preissner, and S. M. Kanse A key role for Toll-like receptor-3 in disrupting the hemostasis balance on endothelial cells Blood, January 15, 2009; 113(3): 714 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Ranjith-Kumar, K. E. Duffy, J. L. Jordan, A. Eaton-Bassiri, R. Vaughan, S. A. Hoose, R. J. Lamb, R. T. Sarisky, and C. C. Kao Single-Stranded Oligonucleotides Can Inhibit Cytokine Production Induced by Human Toll-Like Receptor 3 Mol. Cell. Biol., July 15, 2008; 28(14): 4507 - 4519. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |